Treasury Chief Rachel Reeves Intends Specific Measures on Household Expenses in Forthcoming Budget

Chancellor Rachel Reeves has revealed she is preparing "specific steps to deal with cost of living issues" in next month's Budget.

During an interview with the BBC, she noted that reducing inflation is a collective duty of both the administration and the Bank of England.

The UK's price growth is projected to be the highest among the G7 industrialized countries this calendar year and next.

Possible Utility Cost Interventions

Sources suggest the administration could take action to reduce energy bills, such as by slashing the present 5% level of VAT applied on energy.

Another option is to lower some of the government charges currently added to bills.

Budgetary Limitations and Expert Predictions

The administration will obtain the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much scope there is for these actions.

The expectation from the majority of economists is that Reeves will have to introduce higher taxes or spending cuts in order to fulfill her voluntary debt limits.

Earlier on Thursday, calculations showed there was a £22 billion shortfall for the chancellor to resolve, which is at the lower end of expectations.

"It is a joint task between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor informed the BBC in Washington, at the conferences of the IMF and global financial institution.

Revenue Commitments and International Issues

While a great deal of the focus has been on expected tax rises, the chancellor said the most recent figures from the OBR had not changed her vow to campaign commitments not to increase tax levels on earnings tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with increasing international and trade issues for the fiscal revenue measures, probably to be targeted on those "wealthiest."

International Trade Disputes

Commenting on apprehensions about the United Kingdom's economic relations with China she said: "Our national security invariably take priority."

Last week's declaration by China to strengthen trade restrictions on critical minerals and other materials that are crucial for advanced tech manufacturing led American leader the US President to threaten an additional 100% import tax on goods from China, increasing the risk of an all-out commercial conflict between the two economic giants.

The American finance chief labeled China's move "commercial pressure" and "a international production control attempt."

Asked about considering the US offer to join its dispute with China, the Chancellor said she was "deeply worried" by China's actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "bad for the world economy and generates further obstacles."

"In my view there are sectors where we should address China, but there are also important prospects to export to Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that equilibrium right."

The Treasury chief also stated she was collaborating with international partners "on our own critical minerals approach, so that we are more independent."

NHS Drug Pricing and Funding

Reeves also acknowledged that the price the NHS pays for medicines could rise as a consequence of ongoing discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning operations in the United Kingdom, with several blaming the low prices they are getting.

Recently, the Science Minister said the cost the NHS pays for drugs would have to rise to halt companies and pharmaceutical investment leaving the United Kingdom.

The Chancellor told media: "We have seen as a result of the pricing regime, that clinical trials, recent pharmaceuticals have not been available in the United Kingdom in the way that they are in other European countries."

"Our aim is to ensure that individuals receiving treatment from the NHS are can access the top essential medicines in the globe. And so we are examining all of that, and... looking to attract more funding into Britain."